Tech Company Financing Transactions

TRACON Pharmaceuticals Funding Round

TRACON Pharmaceuticals, based in San Diego, secured $27 million in investment from Arcus Ventures, BioMed Ventures and Brookline Venture Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

4350 La Jolla Village Dr. 800
San Diego, CA 92122
USA

Phone

(858) 550-0780

Website

www.traconpharma.com

Email Address

[email protected]

Overview

TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) is a biotechnology company developing next-generation targeted therapies for cancer and related diseases. We are addressing unmet needs in this arena with product candidates that focus on cellular targets specifically implicated in cancer growth and angiogenesis.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Charles Theuer

        

Vice President

Jennifer Ellis

        

VP - Operations

Bonne Adams

        

VP - Product Management

Sharon Real

        

VP - Regulatory Affairs

Suzy Benedict

        

Browse more venture capital transactions:

Prev: 9/22/2014: Agilence venture capital transaction
Next: 9/22/2014: PerceptiMed venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary